Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Research    crawled time : 20:20    save search

AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024
Published: 2024-03-09 (Crawled : 20:20) - prnewswire.com
BEIGF | $14.29 -9.87% 2.1K twitter stocktwits trandingview |
n/a
| Email alert Add to watchlist
CCXI | News | $51.99 -0.04% twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
BGNE | $144.0 3.61% 3.48% 220K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
AMGN | News | $273.085 -0.17% -0.17% 2.5M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

otezla research
ISOMORPHIC LABS ANNOUNCES STRATEGIC MULTI-TARGET RESEARCH COLLABORATION WITH LILLY
Published: 2024-01-07 (Crawled : 20:20) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

research collaboration
Accent Therapeutics Presents Data Supporting DHX9 Inhibition as a Novel Therapeutic Modality at American Association for Cancer Research (AACR) Annual Meeting 2023
Published: 2023-04-16 (Crawled : 20:20) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
| Email alert Add to watchlist

association cancer research meeting therapeutics
Affimed Presents Final Data Demonstrating Safety and Efficacy of AFM13 Phase 2 REDIRECT Study in Patients with Heavily Pretreated Relapsed or Refractory Peripheral T Cell Lymphoma at the American Association for Cancer Research Annual Meeting 2023
Published: 2023-04-16 (Crawled : 20:20) - globenewswire.com
AFMD | $4.91 -8.22% -8.96% 65K twitter stocktwits trandingview |
Health Technology
| | O: 4.71% H: 5.81% C: 2.93%

afm13 association cancer cell research meeting study
New Research Confirms that Zio® by iRhythm Provides High Value From a Health Economic Perspective
Published: 2022-11-06 (Crawled : 20:20) - globenewswire.com
IRTC | $116.43 0.08% 0.08% 330K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

zio research health irhythm
HealthMetrix Research Selects 2023 Medicare Advantage Plans for Exceptional Benefit Value & Overall Performance
Published: 2022-10-15 (Crawled : 20:20) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
| Email alert Add to watchlist

research
Cryptocurrency Market to Reach $4.94 Billion, Globally, By 2030 at 12.8% CAGR: Allied Market Research
Published: 2022-01-23 (Crawled : 20:20) - prnewswire.com
NVDA | News | $796.78 -3.33% -4.92% 50M twitter stocktwits trandingview |
Electronic Technology
| | O: -4.47% H: 4.7% C: 4.67%
INTC | $34.49 0.61% 0.61% 49M twitter stocktwits trandingview |
Electronic Technology
| | O: -1.13% H: 1.26% C: 0.89%

research market
Global Equity Research Services Market Sourcing and Procurement Intelligence Report| Top Spending Regions and Market Price Trends| SpendEdge
Published: 2021-11-14 (Crawled : 20:20) - prnewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M twitter stocktwits trandingview |
Finance
| | O: 0.94% H: 0.0% C: 0.0%

research
Lilly Presents New Data on Retevmo® (selpercatinib) in Advanced RET Fusion-Positive Gastrointestinal and Other Cancers at 2021 American Association for Cancer Research (AACR) Annual Meeting
Published: 2021-04-11 (Crawled : 20:20) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.57% H: 0.28% C: -0.88%

test positive cancer gastrointestinal research
Oncocyte Presents New Data at 2021 American Association for Cancer Research Annual Meeting Demonstrating Potential for Pan-Cancer Utility of DetermaIO™
Published: 2021-04-10 (Crawled : 20:20) - globenewswire.com
OCX | News | $2.3 -6.31% -6.74% 41K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

potential cancer research
PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for Cancer Research Annual Meeting 2021
Published: 2021-04-10 (Crawled : 20:20) - globenewswire.com
PMVP | $1.69 -6.37% -6.8% 200K twitter stocktwits trandingview |
Commercial Services
| Email alert Add to watchlist

cancer research preclinical pre-clinical
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.